Back to Search
GREGORY CHRONOWSKI, M.D.
M.D.
Radiation Oncology Physician
NPI: 1598789570IndividualAccepts Medicare
Specialties, Licenses & Credentials
Radiation Oncology PhysicianPrimary
Radiology — Radiation Oncology
Code: 2085R0001X
M2924(TX)MD2018-0864(NM)
CMS Specialties
PrimaryRADIATION ONCOLOGY
Education
JEFFERSON MEDICAL COLLEGE OF THOMAS JEFFERSON UNIVERSITY
Class of 1998
Research & Publications (10)
Second malignancies after chemotherapy and radiotherapy for Hodgkin disease.
PMID 14758137·Am J Clin Oncol·2004
8-other
Analysis of in-field control and late toxicity for adults with early-stage Hodgkin's disease treated with chemotherapy followed by radiotherapy.
PMID 12504034·Int J Radiat Oncol Biol Phys·2003
8-other
An elevated serum beta-2-microglobulin level is an adverse prognostic factor for overall survival in patients with early-stage Hodgkin disease.
PMID 12467067·Cancer·2002
3-trial
Treatment of unicentric and multicentric Castleman disease and the role of radiotherapy.
PMID 11505414·Cancer·2001
8-other
Prospective risk-adjusted [18F]Fluorodeoxyglucose positron emission tomography and computed tomography assessment of radiation response in head and neck cancer.
PMID 19332725·J Clin Oncol·2009
3-trial
Reduce in variation and improve efficiency of target volume delineation by a computer-assisted system using a deformable image registration approach.
PMID 17674982·Int J Radiat Oncol Biol Phys·2007
8-other
Comparison between CT-based volumetric calculations and ICRU reference-point estimates of radiation doses delivered to bladder and rectum during intracavitary radiotherapy for cervical cancer.
PMID 15850913·Int J Radiat Oncol Biol Phys·2005
4-observational
Special report: results of the 2000-2002 Association of Residents in Radiation Oncology (ARRO) surveys.
PMID 15093928·Int J Radiat Oncol Biol Phys·2004
8-other
European Organization for Research and Treatment of Cancer and Groupe d'Etude des Lymphomes de l'Adulte very favorable and favorable, lymphocyte-predominant Hodgkin disease.
PMID 11920535·Cancer·2002
3-trial
Phase I and pharmacological study of two schedules of the antifolate edatrexate in combination with cisplatin.
PMID 11297240·Clin Cancer Res·2001
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1515 HOLCOMBE BLVD, 77030-4009
HOUSTON, TX 77030 - Phone
- (713) 792-6161
Quick Facts
- NPI
- 1598789570
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 28
- Publications
- 10
Are you this provider?
Claim Your Profile